Aaron Scherer(@amscherer) 's Twitter Profile Photo

Our latest HaPPI Survey Collaborative article in JAMA Internal Medicine:
We suggest two possible reasons why the impact of the full approval of the Pfizer-BioNTech didn't match pre-approval expectations

jamanetwork.com/journals/jamai…

Our latest @HaPPISurveys article in @JAMAInternalMed: 
We suggest two possible reasons why the impact of the #FDA full approval of the Pfizer-BioNTech #CovidVaccine didn't match pre-approval expectations

jamanetwork.com/journals/jamai…

#vaccines #CovidVaccine #VisualAbstract
account_circle
Courtney Gidengil(@c_gidengil) 's Twitter Profile Photo

The HaPPI Survey Collaborative collaborative led by Aaron Scherer asked adolescents and their parents whether they intended to get a vaccine. Our findings show there is still a lot of work to do to communicate about safety and efficacy of adolescent vaccination.
cdc.gov/mmwr/volumes/7…

account_circle
Internal Medicine at Iowa(@IntMedatIowa) 's Twitter Profile Photo

Watch Aaron Scherer on KCRG-TV9 as he describes HaPPI Survey Collaborative polling of parent & adolescent opinion on . Who do they trust to give reliable information, how many are likely to get the shot? Dr. Scherer lays out the facts. University of Iowa Health Care

kcrg.com/video/2021/08/…

account_circle
JAMA Internal Medicine(@JAMAInternalMed) 's Twitter Profile Photo

Contrary to pre-licensure predictions, HaPPI Survey Collaborative found that U.S. FDA approval of a had limited impact or demographic differences in vaccination intent. Important to consider when creating public health policy for future ID outbreaks. ja.ma/3MvY7WV

account_circle
JAMA Network Open(@JAMANetworkOpen) 's Twitter Profile Photo

A minority of US parents reported to get for children <5 years old; parents reported concerns about COVID-19 vaccine safety, even among those who will probably vaccinate their child. HaPPI Survey Collaborative ja.ma/3zrxWfD

account_circle